It was 1986 all over again on Wall Street, where a
swiftly led to a
. A steep slide in Chinese equities sent the
(^DJI) down 244 points at its depths and, while shares eventually
recovered somewhat, the blue chip index still ended off by
No More Tears maker
Johnson & Johnson
) bucked a brutal tape to gain 1.69%, but
) was crying a river as it tumbled an
(^GSPC)-worst 11.55% amid concerns over its chronic dry eye
Financials fared worst of all.
) fell 3.05%, its stock now a steal without any help from
The Thief of Baghdad
), meanwhile, horrified sticklers for grammar when it said, "This
day," yet it can scarcely afford to buy a consonant after tumbling
) scored a
and Sun Microsystems owner
(ORCL), which nosedived 9.26% on Friday's summer solstice,
recovered from its
Zero Dark Thirty
hour to trade higher on a cloud-computing agreement with
Today in economics, May new home sales and June consumer confidence
are each out at 10:00 a.m. Eastern. On the corporate front,
Barnes & Noble
Smith & Wesson
(WAG) are all due to announce earnings.
Deutsche Bank begins Buys on
Michael Kors Holdings Ltd
Ralph Lauren Corp
Athletic Apparel: Nike, Inc.
(NKE) is assigned a Buy at Deutsche Bank, which has Holds on
Lululemon Athletica inc.
Under Armour Inc
Becton, Dickinson and Co.
(BDX): Shares are begun with a Buy recommendation and $106.50 price
objective at ISI Group, which says its portfolio of medical devices
can ultimately propel mid single digit top-line growth.
Blackhawk Network Holdings Inc
(HAWK): Jefferies has a Buy on HAWK.
Francesca's Holdings Corp
(FRAN): William Blair rates FRAN a fresh Outperform.
Intuitive Surgical, Inc.
(ISRG): The company is covered at Equal Weight by First Analysis.
Liberty Global PLC
(LBTYA): Macquarie launches the stock at an Outperform.
Mast Therapeutics Inc
(MAST): Shares are picked up at Overweight by Piper Jaffray.
Merrimack Pharmaceuticals Inc
(MACK): Mizuho has a Buy rating and $12 target price on a stock it
says has five upcoming catalysts from Phase II and Phase III
Newell Rubbermaid Inc.
(NWL): The stock is a new Neutral at Goldman Sachs.
(JWN): Maxim Group starts the upscale retailer with a Buy and $70
target amid impressive square footage growth.
Synthetic Biologics Inc
(SYN): Ascendiant Capital Markets covers the small cap stock at a
Buy, assigning a $2.25 target price. Its oral beta-lactamase enzyme
(SYN-004) to treat C. difficile shows promise.
Stock Upgrades: Lam Research Corporation Has
Bears on the Run
Stock Downgrades: Netflix, Inc. Now Swimming